Abbott Laboratories (NYSE: ABT) reported its first quarter 2025 earnings results today.
Total sales increased 4% year-over-year to $10.35 billion. Organic sales growth was 6.9%.
Net earnings grew 8.2% to $1.32 billion compared to last year. GAAP earnings per share increased 8.6% to $0.76 while adjusted EPS rose 11.2% to $1.09.
Abbott expects full-year 2025 organic sales growth to be 7.5-8.5% and adjusted EPS to be $5.05-5.25. For the second quarter of 2025, adjusted EPS is expected to be $1.23-1.27.
(This story will be updated shortly with an infographic)
The post Abbott Laboratories (ABT) Q1 2025 Earnings: Key financials and quarterly highlights first appeared on AlphaStreet.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
